Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention (Q34461548)
Jump to navigation
Jump to search
scientific article published on March 1, 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention |
scientific article published on March 1, 1998 |
Statements
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention (English)
S. L. Morgan
J. E. Baggott
1 March 1998